Frequency of adverse events was similar, but fewer propofol patients reported pain or memory of the procedure.
Alfentanil is an ultrashort-acting opioid that induces analgesia for 7 to 9 minutes. In a single-blind (patient blinded), randomized, controlled trial, investigators at an urban county medical center compared alfentanil with propofol for procedural sedation when a moderate depth of sedation was targeted.
Depth of sedation was monitored by trained research assistants using the 5-point observer's assessment of alertness/sedation (OAA/S) score (deeper sedation is indicated by a lower score). Patients received opioids for pain relief before the procedure, but the study drugs were given at least 20 minutes after the last dose. Doses were 10 µg/kg for alfentanil and 1 mg/kg for propofol, followed by additional doses of half the initial bolus every…
Reviewing Author
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals